Zelira Therapeutics Ltd. is a bio-pharmaceutical company. The firm engages in the research and development of cannabinoid-based formulations for the treatment of a variety of medical conditions. It focuses on human clinical trial program and pre-clinical research program. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Zelira Therapeutics Limited?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Zelira Therapeutics Limited market cap is $4.52M.
What is the 52-week high for Zelira Therapeutics Limited?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Zelira Therapeutics Limited 52 week high is $0.5078 as of October 10, 2025.
What is the 52-week low for Zelira Therapeutics Limited?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Zelira Therapeutics Limited 52 week low is $0.2116 as of October 10, 2025.
What is Zelira Therapeutics Limited stock price today?
Zelira Therapeutics Limited stock price today is $0.2116.
What was Zelira Therapeutics Limited stock price yesterday?
Zelira Therapeutics Limited stock price yesterday was $0.2636.
What is the PE ratio of Zelira Therapeutics Limited?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Zelira Therapeutics Limited’s P/E ratio is -1.03.
What is the Price-to-Book ratio of Zelira Therapeutics Limited?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Zelira Therapeutics Limited P/B ratio is -0.8612.
What is the 50-day moving average of Zelira Therapeutics Limited?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Zelira Therapeutics Limited 50-day moving average is $0.259.
